Lexaria BioscienceLEXX
13F holders, Q2 2024 (June 30)28holders +3
4new positions
1sold out
1famous investor
$2.78avg. 13F price*
At the end of Q2 2024, 28 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, up 3 from Q1 2024. 4 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($2.8M), Invenomic Capital Management LP ($1.4M) and Geode Capital Management, LLC ($319K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $3.1M |
| Exits | 1 | $58K |
All 13F filers, Q1 2024 → Q2 2024: 1,211,091 shares bought and 42,050 shares sold, net +1,169,041 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Armistice Capital, LLC | 0.07% | New | 1,020,000 | $2.8M |
| Invenomic Capital Management LP | 0.07% | Add +8.5% | 513,573 | $1.4M |
| Geode Capital Management, LLC | 0.00% | Add +15.6% | 114,783 | $319K |
| Vanguard Group Inc. | 0.00% | Add +9.9% | 93,586 | $260K |
| GenTrust, LLC | 0.01% | New | 60,000 | $167K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | Add +23.4% | 48,800 | $136K |
| State Street Corp. | 0.00% | No change | 39,301 | $109K |
| BlackRock Inc. | 0.00% | Add +1720.0% | 27,445 | $76K |
| Welch Group, LLC | 0.00% | No change | 24,000 | $67K |
| Morgan Stanley | 0.00% | Reduce -1.6% | 22,982 | $64K |
| Renaissance Technologies | 0.00% | New | 22,800 | $63K |
| Northern Trust Corp. | 0.00% | No change | 18,389 | $51K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +33.9% | 13,823 | $38K |
| XTX Topco Ltd | 0.00% | Add +22.6% | 12,602 | $35K |
| Royal Bank of Canada | 0.00% | No change | 7,283 | $20K |
| Oakworth Capital, Inc. | 0.00% | No change | 5,000 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +24.7% | 3,370 | $9K |
| Wells Fargo & Company | 0.00% | Add +207.6% | 3,300 | $9K |
| 1832 Asset Management L.P. | 0.00% | No change | 2,686 | $7K |
| Osaic Holdings, Inc. | 0.00% | Add +4.6% | 2,290 | $6K |
| ADAR1 Capital Management, LLC | 0.00% | Reduce -96.5% | 945 | $3K |
| Aspire Private Capital, LLC | 0.00% | No change | 400 | $1K |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $458 |
| Mather Group, Llc. | 0.00% | New | 100 | $363 |
| Bank of America Corp. | 0.00% | Reduce -59.5% | 96 | $267 |
| Allworth Financial LP | 0.00% | No change | 89 | $243 |
| Toronto Dominion Bank | 0.00% | No change | 13 | $36 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $36 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.